Emily C. Brantley, Ph.D.
|2007||University of Alabama, Birmingham, Birmingham, AL, United States|
Mean distance: 21.25 (cluster 6)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Sestero CM, McGuire DJ, De Sarno P, et al. (2012) CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 189: 2918-30|
|Kim SJ, Kim JS, Kim SW, et al. (2012) Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist Translational Oncology. 5: 39-47|
|Zigler M, Kamiya T, Brantley EC, et al. (2011) PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6|
|Kim SJ, Kim JS, Kim SW, et al. (2011) Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer Neoplasia. 13: 167-179|
|Brantley EC, Guo L, Zhang C, et al. (2010) Nitric oxide-mediated tumoricidal activity of murine microglial cells. Translational Oncology. 3: 380-8|
|Langley RR, Fan D, Guo L, et al. (2009) Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. International Journal of Oncology. 35: 665-72|
|Brantley EC, Nabors LB, Gillespie GY, et al. (2008) Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4694-704|
|Brantley EC, Benveniste EN. (2008) Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Molecular Cancer Research : McR. 6: 675-84|